Skip to main content

ADVERTISEMENT

Mary Beth Nierengarten

Feature
06/21/2011
Results of a randomized, double-blind, placebo-controlled, multicenter trial [N Engl J Med. 2011;364(11):1005-1015] show that the addition of omalizumab to guidelines-based therapy improved asthma control, reduced the need for other...
Results of a randomized, double-blind, placebo-controlled, multicenter trial [N Engl J Med. 2011;364(11):1005-1015] show that the addition of omalizumab to guidelines-based therapy improved asthma control, reduced the need for other...
Results of a randomized,...
06/21/2011
First Report Managed Care
11/20/2019
As the push to deliver increasingly higher quality care at lower costs continues to be of the utmost importance, stakeholders and providers are implementing and testing a number of models to see what suits their patient population best.
As the push to deliver increasingly higher quality care at lower costs continues to be of the utmost importance, stakeholders and providers are implementing and testing a number of models to see what suits their patient population best.
As the push to deliver...
11/20/2019
First Report Managed Care
10/17/2019
As politics continue to play an ever-present role in the future of health care, providers, patients, plans, and other professionals are looking for ways to improve care quality and build meaningful, successful connections among their care...
As politics continue to play an ever-present role in the future of health care, providers, patients, plans, and other professionals are looking for ways to improve care quality and build meaningful, successful connections among their care...
As politics continue to play an...
10/17/2019
First Report Managed Care
09/24/2015
Europe and other countries lead the US in bringing biosimilars to market, according to Steven Miller, MD, vice president, chief medical officer, Express Scripts.
Europe and other countries lead the US in bringing biosimilars to market, according to Steven Miller, MD, vice president, chief medical officer, Express Scripts.
Europe and other countries lead...
09/24/2015
First Report Managed Care
10/23/2013
Results of a phase 3, randomized, open-label trial demonstrate the noninferiority in progression-free survival of pazopanib compared with sunitinib in patients with metastatic renal-cell carcinoma.
Results of a phase 3, randomized, open-label trial demonstrate the noninferiority in progression-free survival of pazopanib compared with sunitinib in patients with metastatic renal-cell carcinoma.
Results of a phase 3,...
10/23/2013
First Report Managed Care
04/23/2012
Results of a retrospective study [JAMA. 2012;307(5):476-482] found no difference between safety- and nonsafety-net emergency departments (EDs) in compliance with proposed measures for ED lengths of stay for admitted, transferred, discharged,...
Results of a retrospective study [JAMA. 2012;307(5):476-482] found no difference between safety- and nonsafety-net emergency departments (EDs) in compliance with proposed measures for ED lengths of stay for admitted, transferred, discharged,...
Results of a retrospective study...
04/23/2012
First Report Managed Care
Conference Insider
02/14/2013
Washington, DC—Black females are at the greatest lifetime risk of being diagnosed with and needing a total knee replacement (TKR) for knee osteoarthritis (OA), investigators reported in a study presented at the ACR meeting that looked at race...
Washington, DC—Black females are at the greatest lifetime risk of being diagnosed with and needing a total knee replacement (TKR) for knee osteoarthritis (OA), investigators reported in a study presented at the ACR meeting that looked at race...
Washington, DC—Black females are...
02/14/2013
First Report Managed Care
News Connection
01/20/2015
A systematic literature review was conducted to develop a clinical practice guideline for the dietary and pharmacologic management to prevent nephrolithiasis.
A systematic literature review was conducted to develop a clinical practice guideline for the dietary and pharmacologic management to prevent nephrolithiasis.
A systematic literature review...
01/20/2015
First Report Managed Care
12/21/2018
Retaining quality care at affordable rates is at the top of the list for many patients. But what is being done from the managed care markets to ensure that patients maintain their health without breaking the bank?
Retaining quality care at affordable rates is at the top of the list for many patients. But what is being done from the managed care markets to ensure that patients maintain their health without breaking the bank?
Retaining quality care at...
12/21/2018
First Report Managed Care
02/17/2015
A study compared the effects of intensive therapy and conventional therapy in patients with type 1 diabetes.
A study compared the effects of intensive therapy and conventional therapy in patients with type 1 diabetes.
A study compared the effects of...
02/17/2015
First Report Managed Care